Pierre LaPalme

Pierre Lapalme currently works at GLyPharma Therapeutic, Inc., as Chairman from 2012.
Mr. Lapalme also formerly worked at Rhone-Poulenc Rorer, Inc., as Chief Executive Officer & Executive Vice President, North America Ethypharm, Inc., as President & Chief Executive Officer from 1995 to 2003, Rhone-Poulenc Canada, Inc., as Chairman & Chief Executive Officer from 1979 to 1990, Rhone-Poulenc Pharmaceuticals, Inc., as Chairman & Chief Executive Officer in 1994, Shionogi Pharma, Inc., as Chairman from 2000 to 2008, Bioxel Pharma, Inc., as Chairman from 2002 to 2009, Pediapharm, Inc., as Chairman from 2013 to 2018, Medexus Pharmaceuticals, Inc., as Chairman from 2013 to 2018, BioMarin Pharmaceutical, Inc., as Director from 2015 to 2016, Æterna Zentaris, Inc., as Independent Director from 2012 to 2016, BioCapital Investment Advisors, Inc., as Director from 2003 to 2005, Confab, Inc., as Director, National Pharmaceutical Council, as Director, Algorithme Pharma, Inc., as Director, Canada's Research Based Pharmaceutical Cos., as Director, Pharmaceutical Manufacturers Association of Canada, as Director, INSYS Therapeutics, Inc., as Independent Director from 2011 to 2019, Sciele Pharmaceuticals, Inc., as Director from 2000 to 2008, Ciba-Geigy Corp., as Senior Vice President-Sales & Marketing, and Sanofi, as Senior Vice President & GM-North America Ethicals.